Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 12/20 | 0.55 |
| ▸ | AURKB | Q96GD4 | 8/20 | 0.48 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.48 |
| ▸ | CSF1R | P07333 | 1/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.48 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.47 |
| ▸ | KDR | P35968 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | BRAF | P15056 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13430228 | 0.89 | AURKA (0.69) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13399935 | 0.81 | AURKA (0.82) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13399937 | 0.80 | AURKA (0.80) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13430277 | 0.79 | AURKA (0.52) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13430238 | 0.79 | AURKA (0.56) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13430283 | 0.79 | AURKA (0.54) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13430229 | 0.78 | AURKA (0.56) | AURKAAURKBKDREGFR | |
| SCHEMBL13430224 | 0.77 | AURKA (0.53) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13430281 | 0.75 | AURKA (0.49) | AURKAAURKBNTRK1CSF1RFLT3 | |
| SCHEMBL13430291 | 0.74 | AURKA (0.49) | AURKAAURKBNTRK1CSF1RFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765953-B2 | Compounds and methods for the treatment of pain and other diseases | AQUILUS PHARMACEUTICALS, INC. (US) | 2014-07-01 | — | — | US | disclosed |
| WO-2010036629-A2 | FUSED MULTICYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2010-04-01 | — | — | WO | disclosed |